| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |